|
|
Article: Alpharma Announces FDA Approval for Albuterol Inhalation Aerosol
- Article from:
- PR Newswire
- Article date:
- August 26, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FORT LEE, N.J., Aug. 26 /PRNewswire/ -- Alpharma Inc. (NYSE: ALO) today announced that its U.S. Pharmaceuticals Division (USPD) has received approval from the Food and Drug Administration to manufacture and market Albuterol Inhalation Aerosol, 90 mcg/Actuation.
Albuterol Inhalation Aerosol is the generic equivalent to Ventolin(R) Inhalation Aerosol from Allen and Hanburys, a division of Glaxo Inc., and is indicated for the prevention and relief of bronchospasm due to asthma and similar respiratory diseases.
Albuterol Inhalation Aerosol is Alpharma USPD's entry into a $500 million annual market. It represents another member of the respiratory ...